Abbott must pay $495m in premature infant formula trial
- Abbott Laboratories must pay $495 million in damages after a Missouri jury found it liable for a girl's serious gastrointestinal disease linked to its formula.
- The jury awarded $95 million in compensatory damages and $400 million in punitive damages, with half for the girl and half for Missouri.
- Abbott disagreed with the verdict and blamed the girl's condition on birth trauma, stating it would pursue an appeal.
19 Articles
19 Articles
Jury orders Abbott to pay $495 million in infant formula trial
A jury on Friday found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay $495 million in damages. The verdict in St. Louis, Missouri state court comes in the first trial against the company out of hundreds of similar claims over the formula pending in courts around the country, which Reuters viewed via Courtroom View Network. Il…
Ekstra Bladet
Kristeligt DagbladI Illinois har en pige udviklet den alvorlige sygdom NEC på grund af bestemt modermælkserstatning, lyder dom
A jury in Saint Louis, United States on Friday ordered Abbott Laboratories to pay 495 million dollars (almost 456 million euros) because Abbott had concealed the risks of drinking baby milk called Similac Special Care 24.
Abbott Pharmaceutical Company must pay $495 million in damages to the mother of a premature baby.
Baby Formula lawsuit in STL leads to $495M verdict
ST. LOUIS - A jury in St. Louis on Friday ordered Abbott Laboratories, the maker of Similac, to pay $95 million in compensatory damages and $400 million in punitive damages. Soon after the verdict, the company stated it would pursue all avenues to have the decision overturned. The case centered around Margo Gill, an Illinois mother and her three-year-old daughter, Robynn, who was hospitalized with major medical problems. Jack Garvey, an attorney…
Abbott must pay US$495m in premature infant formula trial that caused girl to develop bowel disease, jury finds
ST LOUIS, July 27 — A jury on Friday found that Abbott Laboratories’ specialised formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay US$495 million (RM2.3 billion) in damages. The verdict in St Louis, Missouri state court comes in the first trial against the company out of hundreds of similar claims over the formula pending in courts around the country, which Reuters …
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
